Table 3. Correlation between peak growth hormone level and clinical and laboratory parameters

	PGH-T		PGH-L		PGH-A
	r	P-value	r	P-value	r	P-value
Age	0.14	0.261	0.09	0.454	0.02	0.890
Bone age	0.11	0.367	0.07	0.570	–0.01	0.940
Height SDS	–0.03	0.784	–0.06	0.642	0.01	0.933
Weight SDS	–0.22	0.079	–0.32	0.007	–0.04	0.748
BMI SDS	–0.26	0.029	–0.36	0.003	–0.09	0.488
IGF1	0.13	0.270	0.05	0.663	0.20	0.117
Insulin	–0.004	0.977	–0.03	0.814	–0.03	0.803
Glucose	–0.02	0.902	–0.12	0.324	0.05	0.705
HOMA-IR	–0.01	0.957	–0.06	0.644	–0.02	0.862
Total cholesterol	0.22	0.075	0.08	0.528	0.2	0.074
Triglyceride	–0.22	0.073	–0.18	0.133	–0.19	0.137
HDL-C	0.38	0.002	0.20	0.098	0.41	0.001
LDL-C	0.11	0.369	0.0045	0.971	0.17	0.181
AST	0.01	0.912	–0.08	0.541	0.14	0.282
ALT	–0.36	0.004	–0.25	0.049	–0.32	0.012

PGH-T, peak growth hormone level determined by two stimulation tests; PGH-L, peak growth hormone level stimulated by L-dopa; PGH-A, peak growth hormone level stimulated by arginine; SDS, SD score; BMI, body mass index; IGF1, insulin-like growth factor 1; Ln IGF1, log-transformed insulin-like growth factor 1; HOMA-IR, homeostatic model assessment-insulin resistance; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol.